AstraZeneca to cut 1,000 UK jobs with closure of disease research arm

Pharmaceutical company AstraZeneca is to close its disease research arm with the loss of 1,000 UK jobs.

The research and development site based at Charnwood in Leicestershire investigates cures for a number of large disease areas.

A smaller facility in Cambridge will close, and pharmaceutical development work at the Avlon facility near Bristol will also cease.

Some of the workers will move to Alderley Park in Cheshire, AstraZeneca’s largest UK research and development site, the Times has reported.

Sign up to our weekly round-up of HR news and guidance

Receive the Personnel Today Direct e-newsletter every Wednesday

Email(Required)

OptOut

From time to time, we will send you emails about selected products, events and services from Personnel Today and OHW+ - but you can choose to opt-out at any time. If you do not wish to receive these emails, please tick this box.

Comments

This field is for validation purposes and should be left unchanged.

Δ

AstraZeneca said earlier this year that it will cut 8,000 jobs around the world by 2014, including 3,500 in research and development, as part of a large-scale refocusing of the business.

Pharmaceutical companies are pulling research in certain disease areas that have existing treatments which can either cure or manage the condition effectively.